Balance Effects of Morton´s Extension in Flat Foot

August 6, 2024 updated by: EVA MARIA MARTÍNEZ JIMENEZ, Mayuben Private Clinic

Balance Effects of Morton´s Extension in Flat Foot. A Pre-post-test Study.

The aim of this study is to simulate the orthopedic treatment called Morton's extension on flat foot patients to check balance effects in standing position.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The objective of this study is to perform an assimilation of the orthopedic treatment called morton extension on flat foot patients to verify the balance with stabilometry study.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • León, Spain, 24401
        • Eva María Martínez-Jiménez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women and men aged 18 to 30 with flexible flat feet.

Exclusion Criteria:

  • Participants who have had any previous limb surgery, and/or previous lower limb trauma within the last year
  • Uncorrected hearing or visual impairment.
  • Lumbar pathology with radicular involvement.
  • Pregnancy.
  • Healthy participants performing strenuous exercise.
  • Diagnosed active or inactive rheumatic or inflammatory disease.
  • Participants consuming alcohol within 24 hours prior to recording or stimulants 6 hours prior to testing (e.g. caffeine).
  • Participants who have a history of injury with residual lower extremity symptoms within the past year.
  • Participants with evidence of a leg length discrepancy (difference in distance from the anterior superior iliac spine to the superior iliac spine at the surface of the most prominent aspect of the medial malleolus) of more than 1 cm 19
  • Having at least 15 degrees of ankle dorsiflexion.
  • Participants with evidence of balance deficit, as determined through oral questioning about falls and by use of the Balance Evaluation Systems Test (BESTest).
  • Participants with neurological pathology with lower limb deformities, sensory-motor disturbances, neuromuscular pathology, or neurovascular disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Morton.s extension treatment
Appliation of Morton´s extension treatment simulation
Other: Morton extension
A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux of the subjects' bare feet using a paper bandage. The material, shape, size, and thickness of the Morton Extension were the same.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length in millimetres of the centre of pressures. Untreated
Time Frame: Through study completion, an average of 4 days
Length of the centre of pressures described in millimetres.
Through study completion, an average of 4 days
Area of the ellipse. Untreated
Time Frame: Through study completion, an average of 4 days
Area of the ellipse in square millimeters.
Through study completion, an average of 4 days
Inclination of the ellipse in degrees.Untreated
Time Frame: Through study completion, an average of 4 days
Inclination of the ellipse generated by the centre of pressures in 30 seconds in degrees.
Through study completion, an average of 4 days
Length-area ratio. Untreated
Time Frame: Through study completion, an average of 4 days
Fraction of the length of the ellipse between the surface of the ellipse in millimetres.
Through study completion, an average of 4 days
Delta x. Untreated
Time Frame: Through study completion, an average of 4 days
Displacement on the x-axis within the ellipse calculated from the movements of the barycentre. In millimetres.
Through study completion, an average of 4 days
Delta y. Untreated
Time Frame: Through study completion, an average of 4 days
Displacement on the y-axis within the ellipse calculated based on the movements of the barycentre. In millimetres.
Through study completion, an average of 4 days
Displacement on the major axis or y-axis. Untreated
Time Frame: Through study completion, an average of 4 days
Displacement in millimetres of the y-axis.
Through study completion, an average of 4 days
Displacement on the minor axis or x-axis. Untreated
Time Frame: Through study completion, an average of 4 days
Displacement in millimetres of the y-axis.
Through study completion, an average of 4 days
Maximum oscillation. Untreated
Time Frame: Through study completion, an average of 4 days
Measurement of the length in millimetres of the maximum oscillations.
Through study completion, an average of 4 days
Minimum oscillation in millimetres. Untreated
Time Frame: Through study completion, an average of 4 days
Measurement of the length in millimetres of the minimum oscillations
Through study completion, an average of 4 days
Length in millimetres of the centre of pressures with treatment
Time Frame: Through study completion, an average of 4 days
Length of the centre of pressures described in millimetres.
Through study completion, an average of 4 days
Area of the ellipse with treatment
Time Frame: Through study completion, an average of 4 days
Area of the ellipse in square millimeters.
Through study completion, an average of 4 days
Inclination of the ellipse in degrees with treatment
Time Frame: Through study completion, an average of 4 days
Inclination of the ellipse generated by the centre of pressures in 30 seconds in degrees.
Through study completion, an average of 4 days
Length-area ratio with treatment
Time Frame: Through study completion, an average of 4 days
Fraction of the length of the ellipse between the surface of the ellipse in millimetres.
Through study completion, an average of 4 days
Delta x with treatment
Time Frame: Through study completion, an average of 4 days
Displacement on the x-axis within the ellipse calculated from the movements of the barycentre. In millimetres.
Through study completion, an average of 4 days
Delta y with treatment
Time Frame: Through study completion, an average of 4 days
Displacement on the y-axis within the ellipse calculated based on the movements of the barycentre. In millimetres.
Through study completion, an average of 4 days
Displacement on the major axis or y-axis with treatment
Time Frame: Through study completion, an average of 4 days
Displacement in millimetres of the y-axis.
Through study completion, an average of 4 days
Displacement on the minor axis or x-axis with treatment
Time Frame: Through study completion, an average of 4 days
Displacement in millimetres of the y-axis.
Through study completion, an average of 4 days
Maximum oscillation with treatment
Time Frame: Through study completion, an average of 4 days
Measurement of the length in millimetres of the maximum oscillations.
Through study completion, an average of 4 days
Minimum oscillation in millimetres with treatment
Time Frame: Through study completion, an average of 4 days
Measurement of the length in millimetres of the minimum oscillations
Through study completion, an average of 4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayuben Private Clinic

Collaborators

Universidad de León

Investigators

  • Principal Investigator: Eva María Martínez Jiménez, PhD, Universidad Complutense de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2024

Primary Completion (Actual)

August 5, 2024

Study Completion (Actual)

August 6, 2024

Study Registration Dates

First Submitted

July 24, 2024

First Submitted That Met QC Criteria

July 24, 2024

First Posted (Actual)

July 30, 2024

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 6, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24/458-E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Morton extension

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe